Cargando…

The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis

BACKGROUND: Cardiac sarcoidosis (CS) diagnosis is usually based on advanced imaging techniques and multidisciplinary evaluation. Diagnosis is classified as definite, probable, possible or unlikely. If diagnostic confidence remains uncertain, cardiac imaging can be repeated. The objective is to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathijssen, H., Tjoeng, T. W. H., Keijsers, R. G. M., Bakker, A. L. M., Akdim, F., van Es, H. W., van Beek, F. T., Veltkamp, M. V., Grutters, J. C., Post, M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688603/
https://www.ncbi.nlm.nih.gov/pubmed/34928457
http://dx.doi.org/10.1186/s13550-021-00870-y
_version_ 1784618385145856000
author Mathijssen, H.
Tjoeng, T. W. H.
Keijsers, R. G. M.
Bakker, A. L. M.
Akdim, F.
van Es, H. W.
van Beek, F. T.
Veltkamp, M. V.
Grutters, J. C.
Post, M. C.
author_facet Mathijssen, H.
Tjoeng, T. W. H.
Keijsers, R. G. M.
Bakker, A. L. M.
Akdim, F.
van Es, H. W.
van Beek, F. T.
Veltkamp, M. V.
Grutters, J. C.
Post, M. C.
author_sort Mathijssen, H.
collection PubMed
description BACKGROUND: Cardiac sarcoidosis (CS) diagnosis is usually based on advanced imaging techniques and multidisciplinary evaluation. Diagnosis is classified as definite, probable, possible or unlikely. If diagnostic confidence remains uncertain, cardiac imaging can be repeated. The objective is to evaluate the usefulness of repeated cardiac magnetic resonance imaging (CMR) and fluorodeoxyglucose positron emission tomography (FDG PET/CT) for CS diagnosis in patients with an initial “possible” CS diagnosis. METHODS: We performed a retrospective cohort study in 35 patients diagnosed with possible CS by our multidisciplinary team (MDT), who received repeated CMR and FDG PET/CT within 12 months after diagnosis. Imaging modalities were scored on abnormalities suggestive for CS and classified as CMR+/PET+, CMR+/PET−, CMR−/PET+ and CMR−/PET−. Primary endpoint was final MDT diagnosis of CS. RESULTS: After re-evaluation, nine patients (25.7%) were reclassified as probable CS and 16 patients (45.7%) as unlikely CS. Two patients started immunosuppressive treatment after re-evaluation. At baseline, eleven patients (31.4%) showed late gadolinium enhancement (LGE) on CMR (CMR+) and 26 (74.3%) patients showed myocardial FDG-uptake (PET+). At re-evaluation, nine patients (25.7%) showed LGE (CMR+), while 16 patients (45.7%) showed myocardial FDG-uptake (PET+). When considering both imaging modalities together, 82.6% of patients with CMR−/PET+ at baseline were reclassified as possible or unlikely CS, while 36.4% of patients with CMR+ at baseline were reclassified as probable CS. Three patients with initial CMR−/PET+ showed LGE at re-evaluation. CONCLUSION: Repeated CMR and FDG PET/CT may be useful in establishing or rejecting CS diagnosis, when initial diagnosis is uncertain. However, clinical relevance has to be further determined. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13550-021-00870-y.
format Online
Article
Text
id pubmed-8688603
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-86886032022-01-05 The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis Mathijssen, H. Tjoeng, T. W. H. Keijsers, R. G. M. Bakker, A. L. M. Akdim, F. van Es, H. W. van Beek, F. T. Veltkamp, M. V. Grutters, J. C. Post, M. C. EJNMMI Res Original Research BACKGROUND: Cardiac sarcoidosis (CS) diagnosis is usually based on advanced imaging techniques and multidisciplinary evaluation. Diagnosis is classified as definite, probable, possible or unlikely. If diagnostic confidence remains uncertain, cardiac imaging can be repeated. The objective is to evaluate the usefulness of repeated cardiac magnetic resonance imaging (CMR) and fluorodeoxyglucose positron emission tomography (FDG PET/CT) for CS diagnosis in patients with an initial “possible” CS diagnosis. METHODS: We performed a retrospective cohort study in 35 patients diagnosed with possible CS by our multidisciplinary team (MDT), who received repeated CMR and FDG PET/CT within 12 months after diagnosis. Imaging modalities were scored on abnormalities suggestive for CS and classified as CMR+/PET+, CMR+/PET−, CMR−/PET+ and CMR−/PET−. Primary endpoint was final MDT diagnosis of CS. RESULTS: After re-evaluation, nine patients (25.7%) were reclassified as probable CS and 16 patients (45.7%) as unlikely CS. Two patients started immunosuppressive treatment after re-evaluation. At baseline, eleven patients (31.4%) showed late gadolinium enhancement (LGE) on CMR (CMR+) and 26 (74.3%) patients showed myocardial FDG-uptake (PET+). At re-evaluation, nine patients (25.7%) showed LGE (CMR+), while 16 patients (45.7%) showed myocardial FDG-uptake (PET+). When considering both imaging modalities together, 82.6% of patients with CMR−/PET+ at baseline were reclassified as possible or unlikely CS, while 36.4% of patients with CMR+ at baseline were reclassified as probable CS. Three patients with initial CMR−/PET+ showed LGE at re-evaluation. CONCLUSION: Repeated CMR and FDG PET/CT may be useful in establishing or rejecting CS diagnosis, when initial diagnosis is uncertain. However, clinical relevance has to be further determined. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13550-021-00870-y. Springer Berlin Heidelberg 2021-12-20 /pmc/articles/PMC8688603/ /pubmed/34928457 http://dx.doi.org/10.1186/s13550-021-00870-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Mathijssen, H.
Tjoeng, T. W. H.
Keijsers, R. G. M.
Bakker, A. L. M.
Akdim, F.
van Es, H. W.
van Beek, F. T.
Veltkamp, M. V.
Grutters, J. C.
Post, M. C.
The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
title The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
title_full The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
title_fullStr The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
title_full_unstemmed The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
title_short The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
title_sort usefulness of repeated cmr and fdg pet/ct in the diagnosis of patients with initial possible cardiac sarcoidosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688603/
https://www.ncbi.nlm.nih.gov/pubmed/34928457
http://dx.doi.org/10.1186/s13550-021-00870-y
work_keys_str_mv AT mathijssenh theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT tjoengtwh theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT keijsersrgm theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT bakkeralm theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT akdimf theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT vaneshw theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT vanbeekft theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT veltkampmv theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT gruttersjc theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT postmc theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT mathijssenh usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT tjoengtwh usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT keijsersrgm usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT bakkeralm usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT akdimf usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT vaneshw usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT vanbeekft usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT veltkampmv usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT gruttersjc usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis
AT postmc usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis